Lifecore Biomedical, Inc. provided revenue guidance for full year fiscal 2024. For the period, the company expects revenue to be in the range of $125 million to $130 million, depending on timing of customer shipments in fiscal fourth quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.57 USD | -1.20% | +3.46% | +6.14% |
19/04 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
01/04 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.14% | 201M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024